157 related articles for article (PubMed ID: 31322991)
1. Quality of Life During Chemotherapy for Breast Cancer in a West African Population in Dakar, Senegal: A Prospective Study.
Dano D; Hénon C; Sarr O; Ka K; Ba M; Badiane A; Thiam I; Diene P; Diop M; Dem A; Marino P; Mancini J; Annede P; Gonçalves A; Diouf D; Monneur A
J Glob Oncol; 2019 Jul; 5():1-9. PubMed ID: 31322991
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
[TBL] [Abstract][Full Text] [Related]
3. Late chronotypes are associated with neoadjuvant chemotherapy-induced nausea and vomiting in women with breast cancer.
Lee KM; Jung DY; Hwang H; Kim WH; Lee JY; Kim TY; Im SA; Lee KH; Spiegel D; Hahm BJ
Chronobiol Int; 2017; 34(4):480-491. PubMed ID: 28362229
[TBL] [Abstract][Full Text] [Related]
4. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors.
Yeo W; Pang E; Liem GS; Suen JJS; Ng RYW; Yip CCH; Li L; Yip CHW; Mo FKF
Health Qual Life Outcomes; 2020 Feb; 18(1):24. PubMed ID: 32041627
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
[TBL] [Abstract][Full Text] [Related]
6. [The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study].
Ishihara Y; Nukariya N; Kobayashi K; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):745-55. PubMed ID: 8645026
[TBL] [Abstract][Full Text] [Related]
7. Quality of life analyses in a clinical trial of DPPE (tesmilifene) plus doxorubicin versus doxorubicin in patients with advanced or metastatic breast cancer: NCIC CTG Trial MA.19.
Liu J; Tu D; Dancey J; Reyno L; Pritchard KI; Pater J; Seymour LK
Breast Cancer Res Treat; 2006 Dec; 100(3):263-71. PubMed ID: 16823511
[TBL] [Abstract][Full Text] [Related]
8. A prospective observational study of chemotherapy-induced adverse drug reaction and the quality of life in cancer patients in a tertiary care hospital.
Krishnarajan D; Sivasakthi K; Ariyamol R; Kumar DN; Varghese S
J Cancer Res Ther; 2021; 17(2):530-536. PubMed ID: 34121703
[TBL] [Abstract][Full Text] [Related]
9. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
[TBL] [Abstract][Full Text] [Related]
10. Nausea, vomiting and quality of life of patients with cancer undergoing antineoplastic treatment: an evaluation by pharmacists.
de Souza CM; Visacri MB; Ferrari GB; Tuan BT; Costa AP; Barbosa CR; Lima CS; Mazzola PG; Moriel P
Int J Pharm Pract; 2015 Oct; 23(5):357-60. PubMed ID: 25572714
[TBL] [Abstract][Full Text] [Related]
11. [Nausea, vomiting and quality of life in women with breast cancer receiving chemotherapy].
Gozzo Tde O; Moysés AM; da Silva PR; de Almeida AM
Rev Gaucha Enferm; 2013 Sep; 34(3):110-6. PubMed ID: 24344592
[TBL] [Abstract][Full Text] [Related]
12. [Effects of an anti-emetic tropisetron capsule on QOL of patients with delayed nausea and vomiting induced by cancer chemotherapy. Group for Investigation of QOL Questionnaire for Anti-Emetics used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative Study].
Nukariya N; Kobayashi K; Ishihara Y; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):757-71. PubMed ID: 8645027
[TBL] [Abstract][Full Text] [Related]
13. Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
Schwentner L; Harbeck N; Singer S; Eichler M; Rack B; Forstbauer H; Wischnik A; Scholz C; Huober J; Friedl TW; Weissenbacher T; Härtl K; Kiechle M; Janni W; Fink V
Breast; 2016 Jun; 27():69-77. PubMed ID: 27054751
[TBL] [Abstract][Full Text] [Related]
14. Impact of chemotherapy-induced nausea and vomiting on quality of life in indonesian patients with gynecologic cancer.
Perwitasari DA; Atthobari J; Mustofa M; Dwiprahasto I; Hakimi M; Gelderblom H; Putter H; Nortier JW; Guchelaar HJ; Kaptein AA
Int J Gynecol Cancer; 2012 Jan; 22(1):139-45. PubMed ID: 22080888
[TBL] [Abstract][Full Text] [Related]
15. Negative impact of chemotherapy on breast cancer patients QOL - utility of antiemetic treatment guidelines and the role of race.
Hassan BA; Yusoff ZB
Asian Pac J Cancer Prev; 2010; 11(6):1523-7. PubMed ID: 21338191
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.
Land SR; Kopec JA; Yothers G; Anderson S; Day R; Tang G; Ganz PA; Fisher B; Wolmark N
Breast Cancer Res Treat; 2004 Jul; 86(2):153-64. PubMed ID: 15319567
[TBL] [Abstract][Full Text] [Related]
17. Incidence of chemotherapy-induced nausea and vomiting associated with docetaxel and cyclophosphamide in early breast cancer patients and aprepitant efficacy as salvage therapy. Results from the Spanish Breast Cancer Group/2009-02 study.
Llombart-Cussac A; Ramos M; Dalmau E; García-Saenz JA; González-Farré X; Murillo L; Calvo L; Morales S; Carañana V; González A; Fernández-Morales LA; Moreno F; Casas MI; Angulo Mdel M; Cámara MC; Garcia-Mace AI; Carrasco E; Jara-Sánchez C
Eur J Cancer; 2016 May; 58():122-9. PubMed ID: 26994459
[TBL] [Abstract][Full Text] [Related]
18. Nutritional Intervention Contributes to the Improvement of Symptoms Related to Quality of Life in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Randomized Clinical Trial.
Souza APS; Silva LCD; Fayh APT
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33579050
[TBL] [Abstract][Full Text] [Related]
19. Cross-cultural comparison of breast cancer patients' Quality of Life in the Netherlands and Japan.
Fischer MJ; Inoue K; Matsuda A; Kroep JR; Nagai S; Tozuka K; Momiyama M; Weijl NI; Langemeijer-Bosman D; Ramai SRS; Nortier JWR; Putter H; Yamaoka K; Kubota K; Kobayashi K; Kaptein AA
Breast Cancer Res Treat; 2017 Nov; 166(2):459-471. PubMed ID: 28762012
[TBL] [Abstract][Full Text] [Related]
20. Impact of cancer-related fatigue on chemotherapy-induced nausea and vomiting in Asian cancer patients.
Poon KS; Un MK; Low XH; Cheung YT; Yap KY; Chan A
Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1345-51. PubMed ID: 24023040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
